You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com | |
Most viewed
- 1. Targeted cancer drugs may replace chemo for some patients — and drugmakers say they're getting closer
- 2. Cardiovascular adverse effects of immunotherapy in cancer: insights and implications
- 3. Research progress on FOXM1 in ovarian cancer diagnosis and therapeutics
- 4. Fusobacterium nucleatum promotes metastasis of breast cancer via the miR-21-3p/FOXO3 axis
- 5. A pan-cancer analysis of the prognostic and immunological roles of zinc finger protein 514 in human tumors
- 6. Singlera Genomics and Partners publish results from GUIDE prospective cohort study demonstrating blood-based early detection of gastrointestinal cancers using DNA methylation-based GutSeer assay
- 7. Amplia Therapeutics achieves second complete response with narmafotinib in pancreatic cancer trial
- 8. Development and validation of hybrid machine learning approach for predicting survival in patients with cervical cancer: a SEER-based population study
- 9. Human annexin A5 promotes glioma progression by targeting the MAPK/CD44 pathway
- 10. PreciseDx Secures $11M in New Funding
Last updated at 22:53 GMT
Hot News Makers
Health/Pharma Companies
- 1560264.46
- 20418.63
- 8506.98
- 6910.72
- 6311.91
- 5711.49
- 5159.97
- 5073.15
- 4352.04
- 4127.44
Drugs, Treatments, Trials
- 9142.03
- 5448.22
- 4422.16
- 2898.86
- 2083.39
- 1649.12
- 1257.73
- 1222.83
- 1206.90
- 1129.86
Last updated at 22:10 GMT
